These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 35453226)
1. Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic. Ali W; Elsahn A; Ting DSJ; Dua HS; Mohammed I Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453226 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional cationic host defence peptides and their clinical applications. Yeung AT; Gellatly SL; Hancock RE Cell Mol Life Sci; 2011 Jul; 68(13):2161-76. PubMed ID: 21573784 [TBL] [Abstract][Full Text] [Related]
4. The Building Blocks of Antimicrobial Resistance in Langendonk RF; Neill DR; Fothergill JL Front Cell Infect Microbiol; 2021; 11():665759. PubMed ID: 33937104 [No Abstract] [Full Text] [Related]
5. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. Choi KY; Chow LN; Mookherjee N J Innate Immun; 2012; 4(4):361-70. PubMed ID: 22739631 [TBL] [Abstract][Full Text] [Related]
6. Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides. Balhuizen MD; van Dijk A; Jansen JWA; van de Lest CHA; Veldhuizen EJA; Haagsman HP mSphere; 2021 Aug; 6(4):e0052321. PubMed ID: 34232080 [TBL] [Abstract][Full Text] [Related]
7. Strategies in Translating the Therapeutic Potentials of Host Defense Peptides. Ting DSJ; Beuerman RW; Dua HS; Lakshminarayanan R; Mohammed I Front Immunol; 2020; 11():983. PubMed ID: 32528474 [TBL] [Abstract][Full Text] [Related]
8. Phytochemicals as Antimicrobials: Prospecting Himalayan Medicinal Plants as Source of Alternate Medicine to Combat Antimicrobial Resistance. Ashraf MV; Pant S; Khan MAH; Shah AA; Siddiqui S; Jeridi M; Alhamdi HWS; Ahmad S Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375828 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides? Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; Morales delaNuez A Front Immunol; 2022; 13():921483. PubMed ID: 35720330 [TBL] [Abstract][Full Text] [Related]
13. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections. Li J; Fernández-Millán P; Boix E Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698 [TBL] [Abstract][Full Text] [Related]
14. Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities. Rayan RA World J Clin Cases; 2023 Feb; 11(6):1267-1274. PubMed ID: 36926133 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of HDPs as immunomodulatory agents. Jenssen H; Hancock RE Methods Mol Biol; 2010; 618():329-47. PubMed ID: 20094873 [TBL] [Abstract][Full Text] [Related]
16. A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic. Rehman S J Infect Public Health; 2023 Apr; 16(4):611-617. PubMed ID: 36857834 [TBL] [Abstract][Full Text] [Related]
17. The future of recombinant host defense peptides. Roca-Pinilla R; Lisowski L; Arís A; Garcia-Fruitós E Microb Cell Fact; 2022 Dec; 21(1):267. PubMed ID: 36544150 [TBL] [Abstract][Full Text] [Related]
18. Multiple roles of ribosomal antimicrobial peptides in tackling global antimicrobial resistance. Luong HX; Ngan HD; Thi Phuong HB; Quoc TN; Tung TT R Soc Open Sci; 2022 Jan; 9(1):211583. PubMed ID: 35116161 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era. Saini J; Kaur P; Malik N; Lakhawat SS; Sharma PK Microbiol Res; 2022 Dec; 265():127206. PubMed ID: 36162150 [TBL] [Abstract][Full Text] [Related]